4D Molecular Therapeutics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, 4D Molecular Therapeutics stock has a consensus rating of "Buy" and an average price target of $28.22. The average 1-year stock price forecast is 228.14% higher than the current stock price, while the lowest is $17 (+97.67%) and the highest is $36 (+318.60%).

Price Target: $28.22 (+228.14%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$28.22	$29	$36
Change	+97.67%	+228.14%	+237.21%	+318.60%

* Price targets were last updated on Mar 30, 2026.

Analyst Ratings

The average analyst rating for 4D Molecular Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	4
Buy	4	4	4	3	3	3
Hold	0	0	0	0	0	0
Sell	1	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	8	8	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Faisal Khurshid Jefferies	Jefferies	Strong Buy Initiates $40 → $21	Strong Buy	Initiates	$40 → $21	+144.19%	Mar 30, 2026
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $36	Strong Buy	Reiterates	$36	+318.60%	Mar 20, 2026
Lisa Walter RBC Capital	RBC Capital	Buy Maintains $32 → $35	Buy	Maintains	$32 → $35	+306.98%	Mar 19, 2026
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $26	Strong Buy	Maintains	$26	+202.33%	Mar 19, 2026
Eliana Merle Barclays	Barclays	Buy Initiates $33	Buy	Initiates	$33	+283.72%	Jan 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

13.81M

from 85.21M

-83.80%

from 85.21M

Revenue Next Year

20.19M

from 13.81M

46.23%

from 13.81M

EPS This Year

-4.03

from -2.42

EPS Next Year

-4.09

from -4.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	18.04M	3.13M	20.72M	37.00K	85.21M	13.81M	20.19M
Revenue Growth	32.52%	-82.65%	562.29%	-99.82%	230,194.59%	-83.80%	46.23%
EPS	-2.57	-3.32	-2.58	-2.98	-2.42	-4.03	-4.09
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	31.5M	40.2M
Avg	13.8M	20.2M
Low	2.9M	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-63.0%	191.2%
Avg	-83.8%	46.2%
Low	-96.5%	-

EPS Forecast

EPS	2026	2027
High	-3.61	-3.19
Avg	-4.03	-4.09
Low	-4.28	-4.54

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.